• Glioma Stem Cell Membrane Nanozymes Enable Dual-Targeted GBM

  2026-05-18

  This study introduces a glioma stem cell membrane-camouflaged nanozyme system capable of crossing the blood–brain barrier and delivering doxorubicin for synergistic chemo- and photothermal therapy in glioblastoma models. The innovation provides a significant survival extension in mice and offers new strategies for targeting therapy-resistant tumor subpopulations.

• D-Luciferin (Potassium Salt): Illuminating Photosynthetic an

  2026-05-18

  Explore how D-Luciferin (potassium salt) transforms in vivo bioluminescence imaging and luciferase reporter assays. This article uniquely bridges plant photosynthetic research with advanced animal model applications, deepening understanding for assay design.

• Viperin Disrupts Coronavirus Replication via nsp8-RTC Interf

  2026-05-17

  The referenced study unveils a novel antiviral mechanism by which viperin, an interferon-induced protein, inhibits coronavirus replication. By directly binding to non-structural protein 8 (nsp8), viperin disrupts replication-transcription complex (RTC) assembly independently of its canonical RNA chain-terminating product, ddhCTP. These findings broaden our understanding of viperin's antiviral activity and suggest new strategies for targeting conserved coronavirus machinery.

• Tacrolimus (FK506): Mechanism and Applications in Immunology

  2026-05-16

  Tacrolimus (FK506) is a highly potent, selective macrolide immunosuppressant that inhibits calcineurin via FKBP12 complexation. It is widely used in transplantation immunology research and autoimmune disease models for its precise cytokine pathway modulation. This dossier details its mechanism, quantitative benchmarks, and critical protocol parameters.

• CKI 7 Dihydrochloride: Advancing CK1 Inhibition in Cancer Re

  2026-05-15

  This article explores the mechanistic and translational impact of CKI 7 dihydrochloride, a selective Casein kinase 1 inhibitor, for dissecting key signaling pathways in cancer biology—especially Wnt and circadian rhythm regulation. Building on recent insights into kinase-controlled metastasis in non-small cell lung cancer, we provide strategic guidance for researchers seeking to leverage CKI 7 dihydrochloride in high-impact experimental designs, with evidence-based protocol parameters, workflow recommendations, and a forward-looking perspective on clinical translation.

• Rotigotine: Dopamine D2/D3 Receptor Agonist for Translationa

  2026-05-15

  Rotigotine, a high-affinity dopamine D2/D3 receptor agonist, is redefining experimental Parkinson’s disease research through continuous dopaminergic delivery and robust multi-receptor modulation. This article breaks down in vitro and in vivo applications, protocol optimizations, and troubleshooting steps that maximize reproducibility and data clarity.

• Palomid 529 (P529) in Overcoming Metastasis and Resistance v

  2026-05-14

  Explore how Palomid 529 (P529) uniquely addresses cancer metastasis and chemoresistance through dual mTORC1/mTORC2 inhibition. This in-depth analysis leverages new mechanistic insights for assay strategy and translational research.

• MOB1A/B Loss Disrupts Intestinal Homeostasis via TGF-β and W

  2026-05-14

  This study reveals that depletion of MOB1A/B in intestinal epithelial cells leads to degeneration through suppression of Wnt activity and activation of BMP/TGF-β signaling. Pharmacological inhibition of the TGF-β pathway with SB 431542 partially restores differentiation of secretory lineages, highlighting a critical regulatory axis for intestinal homeostasis.

• Z-LEHD-FMK: Strategic Caspase-9 Inhibition for Translational

  2026-05-13

  Explore how Z-LEHD-FMK, a selective irreversible caspase-9 inhibitor, empowers translational researchers to dissect mitochondria-mediated apoptosis in cancer and neuroprotection models. This article synthesizes mechanistic insight, recent advances in apoptosis assays, and strategic recommendations for leveraging Z-LEHD-FMK in disease modeling, with evidence from melanoma nanomaterial studies and advanced protocol guidance.

• Glabridin-Gold(I) Complex Targets TrxR/MAPK for Antitumor Im

  2026-05-13

  This study introduces a novel glabridin-gold(I) complex (6d) that synergistically targets thioredoxin reductase and MAPK pathways to enhance antitumor immune responses while mitigating immunosuppression in liver cancer models. The findings highlight mechanistic advances in immunomodulation and offer new directions for combination immunotherapy strategies.

• Strategic Apoptosis Modulation: Caspase-3/7 Inhibitor I in T

  2026-05-12

  This thought-leadership article explores the mechanistic, experimental, and translational facets of Caspase-3/7 Inhibitor I as a tool for apoptosis research. Integrating recent pathogen-induced apoptosis findings, it provides actionable guidance for researchers designing studies in cancer, infection, and cell survival. The article contextualizes APExBIO's inhibitor within contemporary research, protocol best practices, and future clinical translation.

• Niclosamide: Applied STAT3 Inhibition in Cancer Research Wor

  2026-05-12

  Niclosamide’s dual STAT3 and NF-κB inhibition enables precise dissection of oncogenic signaling in both in vitro and in vivo cancer models. This guide delivers actionable protocols, troubleshooting insights, and data-driven performance comparisons for researchers leveraging Niclosamide from APExBIO.

• Optimizing Cell Proliferation with CCK-8: Advanced Use Cases

  2026-05-11

  The Cell Counting Kit-8 (CCK-8) streamlines cell proliferation and cytotoxicity assays with unmatched sensitivity, outperforming legacy methods in both workflow simplicity and quantitative accuracy. This article unpacks advanced applications, experimental refinements, and troubleshooting strategies to maximize the reliability of CCK-8 in translational cancer research and beyond.

• Cinoxacin: Quinolone Antibiotic Workflows for UTI Research

  2026-05-11

  Cinoxacin stands out among quinolone antibiotics for robust, reproducible inhibition of Gram-negative uropathogens in both classic and advanced urinary tract infection models. This guide translates benchmark findings into actionable protocols, troubleshooting strategies, and comparative insights for antibiotic resistance and bacterial DNA synthesis studies.

• Zolmitriptan: 5-HT1B Receptor Agonist Workflows for Migraine

  2026-05-10

  Zolmitriptan stands out as a highly selective 5-HT1B receptor agonist, enabling precise dissection of migraine and cluster headache pathways. This article delivers actionable protocols, advanced troubleshooting, and new insights from lysosomal modulation research to elevate migraine research outcomes.

496 records 14/34 page Previous Next First page 上5页 1112131415 下5页 Last page